-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Teva Pharmaceutical Industries Ltd quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Teva Pharmaceutical Industries Ltd Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$241M, a 10.1% increase year-over-year.
- Teva Pharmaceutical Industries Ltd Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$1.02B, a 0.49% increase year-over-year.
- Teva Pharmaceutical Industries Ltd annual Nonoperating Income (Expense) for 2023 was -$1.06B, a 9.42% decline from 2022.
- Teva Pharmaceutical Industries Ltd annual Nonoperating Income (Expense) for 2022 was -$966M, a 8.7% increase from 2021.
- Teva Pharmaceutical Industries Ltd annual Nonoperating Income (Expense) for 2021 was -$1.06B, a 26.9% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)